<code id='8DF7A5AEF4'></code><style id='8DF7A5AEF4'></style>
    • <acronym id='8DF7A5AEF4'></acronym>
      <center id='8DF7A5AEF4'><center id='8DF7A5AEF4'><tfoot id='8DF7A5AEF4'></tfoot></center><abbr id='8DF7A5AEF4'><dir id='8DF7A5AEF4'><tfoot id='8DF7A5AEF4'></tfoot><noframes id='8DF7A5AEF4'>

    • <optgroup id='8DF7A5AEF4'><strike id='8DF7A5AEF4'><sup id='8DF7A5AEF4'></sup></strike><code id='8DF7A5AEF4'></code></optgroup>
        1. <b id='8DF7A5AEF4'><label id='8DF7A5AEF4'><select id='8DF7A5AEF4'><dt id='8DF7A5AEF4'><span id='8DF7A5AEF4'></span></dt></select></label></b><u id='8DF7A5AEF4'></u>
          <i id='8DF7A5AEF4'><strike id='8DF7A5AEF4'><tt id='8DF7A5AEF4'><pre id='8DF7A5AEF4'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:8458
          Adobe

          It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

          Or is there?

          advertisement

          A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          Drug firms test therapies to halt Alzheimer’s before symptoms arise
          Drug firms test therapies to halt Alzheimer’s before symptoms arise

          SinceFebruary2022,AstridaSchaefferhasdrivenabout160milesroundtripeveryotherweektoBrighamandWomen’sHo

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          AstraZeneca challenges Medicare drug negotiation program

          AstraZenecaissuingtheBidenadministrationtostopanewMedicaredrugpricenegotiationprogram.AdobeWASHINGTO